You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Global Briefing

Generic Drugs in Consumer Health Global Overview 2011

Jul 2011

Price: US$2,000

About this Report

About this Report

Generic drugs are usually associated with prescription (Rx) drugs; however, they are infiltrating the consumer health landscape via “branded generics” and private label across the world. Significant competitive pressures, along with an increasing need for affordable medicines, have caused manufacturers, distributors, marketers and retailers to rethink their strategies regarding generic drugs. Instead of a threat, they are slowly becoming an ally in a strategy to boost sales.


What this report includes

  • Up-to-the minute analysis of the latest trends in the industry
  • New product development, forecasts and other themes
  • Unique graphics and illustrated case studies
  • Most recent brand and company news
  • New insight into the size and shape of the market

Why buy this report

  • Clear, concise powerpoint format makes it easy to digest
  • Leading industry opinion keeps you abreast of latest news and trends
  • Forward-looking outlook on a category, market or issue affecting the industry
  • Latest five year forecasts assess how the market is predicted to develop
  • Understand the competitive environment, the leading players and brands

Delivery format

PDF/PPT
Downloadable from MyPages

Table of Contents

Table of Contents

Introduction

Scope

Objectives

Key findings

Understanding the Role of Generic Drugs In Consumer Health

Moving beyond the generic drug concept

The good and bad side of generic drugs

Creating value from a drug

Expansion into the generics world

The goal to become “first” in the marketplace

A shift in generic drugs strategies

The Economic Effect of Generic Drugs

The contrast in the global adoption of generic drugs

Savings vs the erosion of value

The premium price of branded options

Low prices become the new platform for competition

India, a leading global supplier of generic drugs

The role of income in decision making: the stigma of generics

The psychological link of quality and price perception

Company Profiles – Generic Drugs

Perrigo Co (United States)

Perrigo’s activities related to consumer health

Perrigo’s path to growth in 2010/2011

SWOT Analysis: Perrigo Co

Teva Pharmaceutical Industries Ltd (Israel)

Teva’s activity related to consumer health

SWOT Analysis: Teva Pharmaceutical Industries Ltd

Dr Reddy’s Laboratories (India)

Dr Reddy’s activity related to consumer health

SWOT Analysis: Dr Reddy’s Laboratories

Watson Pharmaceuticals Inc (United States)

Watson’s activity related to consumer health

SWOT Analysis: Watson Pharmaceuticals Inc

The Generic Strategy in a Competitive World

A global king of branding joins a global powerhouse in generics

A global king of branding joins a global powerhouse in generics

Strategy: combining the offer of standard and generic drugs

Synergies of a powerful strategy

Brazil: generic growth on the horizon

Merging local generic expertise with international experience

Searching for generic opportunities in the largest market

The retailing factor in private label and generic drugs

Prospects of Generic Drugs in Consumer Health

The ageing population: how to afford consumer health

Dispensing generic drugs at pharmacies

Generic drugs to see more opportunities in several categories

Drivers shaping the future of generic drugs

Report Definitions

Data parameters and report definitions

Consumer health definitions

Samples

GenericDrugsinconsumerhealthglobal2011.jpg

my pages

Want to find out more about this report?